4.6 Article

The V protein in oncolytic Newcastle disease virus promotes HepG2 hepatoma cell proliferation at the single-cell level

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Optimizing environmental safety and cell-killing potential of oncolytic Newcastle Disease virus with modifications of the V, F and HN genes

J. Frederique de Graaf et al.

Summary: Newcastle Disease Virus (NDV) is a promising agent for oncolytic viral therapy, but its virulence in poultry limits its use. In this study, we developed a mutant NDV with reduced poultry virulence while maintaining effectiveness in killing human tumor cells. By disrupting the V protein ORF and introducing mutations in the fusion and hemagglutinin-neuraminidase genes, we successfully attenuated the virus in avian cells and eggs. Despite a slight decrease in efficacy compared to the virulent NDV, the mutant NDV showed potential as a safe candidate for oncolytic viral therapy evaluation.

PLOS ONE (2022)

Article Virology

Encephalomyocarditis Virus 2A Protein Inhibited Apoptosis by Interaction with Annexin A2 through JNK/c-Jun Pathway

Ruochan Han et al.

Summary: The 2A protein of encephalomyocarditis virus interacts with annexin A2 via the JNK/c-Jun pathway to inhibit apoptosis and promote viral proliferation. These findings contribute to our understanding of the molecular pathogenesis underlying EMCV infection.

VIRUSES-BASEL (2022)

Article Virology

Vaccinia Virus Arrests and Shifts the Cell Cycle

Caroline K. Martin et al.

Summary: Modulation of the host cell cycle is a common strategy used by viruses to create a pro-replicative environment. Vaccinia virus (VACV) has been reported to alter cell cycle regulation and trigger the host cell DNA damage response. This study investigates the effect of VACV infection on cell proliferation and host cell cycle progression. It identifies the viral effectors responsible for inhibiting cell proliferation and shifting the host cell cycle, and reveals the involvement of viral kinases in activating the DNA damage checkpoint and mediating the degradation of checkpoint effectors.

VIRUSES-BASEL (2022)

Article Immunology

Inhibition of cell proliferation by Tas of foamy viruses through cell cycle arrest or apoptosis underlines the different mechanisms of virus-host interactions

Wei Jie et al.

Summary: Foamy viruses cause nonpathogenic infection to hosts in natural conditions, but can induce severe cytopathic effects in vitro. This study reveals the molecular mechanisms by which foamy viruses regulate host cell proliferation and cell cycle to achieve infection, highlighting the importance of virus-host cell interactions.

VIRULENCE (2022)

Article Oncology

Therapeutic potential of the human endogenous retroviral envelope protein HEMO: a pan-cancer analysis

Amelie Kasperek et al.

Summary: Human endogenous retrovirus HEMO is specifically expressed in tumors and may be linked to activation of the Wnt/β-catenin signaling pathway. Tumors with different levels of HEMO expression are negatively associated with immune response signatures. These findings suggest that HEMO could be a promising tumor biomarker and therapeutic target.

MOLECULAR ONCOLOGY (2022)

Article Virology

Non-Metabolic Functions of PKM2 Contribute to Cervical Cancer Cell Proliferation Induced by the HPV16 E7 Oncoprotein

Seoung-Ae Lee et al.

Summary: HPV16 E7 increases PKM2 expression in cervical cancer cells and activates a non-glycolytic function of PKM2 to promote cell proliferation. High PKM2 expression is associated with worse prognosis in HPV+ cervical cancers. Targeting PKM2 may be a potential therapeutic strategy for HPV-associated cervical cancer.

VIRUSES-BASEL (2021)

Article Immunology

Newcastle Disease Virus Inhibits the Proliferation of T Cells Induced by Dendritic Cells In Vitro and In Vivo

Fu Long Nan et al.

Summary: This study reveals that DCs undergo phenotypic maturation but are dysfunctional in priming T cell responses during NDV infection, leading to curtailed immune responses.

FRONTIERS IN IMMUNOLOGY (2021)

Review Oncology

The MEK/ERK Network as a Therapeutic Target in Human Cancer

Renee Barbosa et al.

Summary: The RAS-RAF-MEK-ERK pathway is crucial for cell proliferation, differentiation, and survival, with mutations in upstream proteins RAS and RAF contributing to many human cancers and nearly all cutaneous melanomas. Targeting terminal kinases in the MAPK cascade has shown promise in overcoming drug resistance and improving treatment options for patients with MAPK-aberrant cancers.

MOLECULAR CANCER RESEARCH (2021)

Article Biology

Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis

Mohsen Keshavarz et al.

SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2020)

Article Immunology

Newcastle Disease Virus V Protein Inhibits Cell Apoptosis and Promotes Viral Replication by Targeting CacyBP/SIP

Zhili Chu et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)

Article Veterinary Sciences

Newcastle disease virus V protein inhibits apoptosis in DF-1 cells by downregulating TXNL1

Caiying Wang et al.

VETERINARY RESEARCH (2018)

Article Cell Biology

Signaling Pathways that Control Cell Proliferation

Robert J. Duronio et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)

Article Multidisciplinary Sciences

Structure and assembly of a paramyxovirus matrix protein

Anthony J. Battisti et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Multidisciplinary Sciences

Mammalian MAP kinase signalling cascades

LF Chang et al.

NATURE (2001)